ASO Visual Abstract: Talimogene Laherparepvec (T-VEC) for Treatment of Advanced Locoregional Melanoma after Failure of Immunotherapy: An International Multi-institutional Experience

Authors :: Syeda Mahrukh Hussnain Naqvi
Young-Chul Kim
Alexander C.J. van Akkooi
Michael C. Lowe
Yun Song
Frances A. Collichio
David W. Ollila
Richard J. Straker
Keith A. Delman
Jonathan S. Zager
Kristin Baecher
Danielle DePalo
Michael J Carr
Luke D. Rothermel
Emma H. A. Stahlie
Amod A. Sarnaik
Raphael J. Louie
James Sun
Giorgos C. Karakousis
G. Paul Wright
Source :: Annals of Surgical Oncology. 29:804-805
Publication Year :: 2021
Publisher :: Springer Science and Business Media LLC, 2021.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Melanoma
medicine.medical_treatment
Immunotherapy
medicine.disease
Surgical oncology
Internal medicine
medicine
Surgery
Talimogene laherparepvec
business

Tools